Saint Matthews

Researchers are gathering real-world clinical data on the use of radiofrequency catheter ablation technologies to treat patients with symptomatic Paroxysmal and Persistent Atrial Fibrillation. This observational registry aims to evaluate the clinical outcomes, procedural efficiency, safety, and long-term effectiveness of novel ablation devices such as THERMOCOOL SMARTTOUCH and its variants in these patient groups. The study focuses on understanding how well these ablation treatments work in everyday clinical settings beyond controlled trials. Participants undergo ablation treatment using radiofrequency technologies, with procedures performed at selected sites following their standard care practices. Patient assessments are scheduled at multiple time points: before the ablation, during the procedure, and at follow-up visits approximately 10-12 weeks, 6 months, and 1 year after ablation. Monitoring includes heart rhythm tracking and evaluations of arrhythmia recurrence, medication usage, and related symptoms. During the study, participants receive comprehensive evaluations including echocardiograms, medical history reviews, arrhythmia monitoring with continuous heart rhythm devices, and physician assessments. Researchers measure effectiveness at 90 days and 12 months, along with safety outcomes shortly after the procedure and during follow-ups. The total follow-up period spans one year to assess long-term treatment impact and patient quality of life improvements.